DK1214097T3 - Nukleinsyrer kodende for polyepitop-polypeptider - Google Patents

Nukleinsyrer kodende for polyepitop-polypeptider

Info

Publication number
DK1214097T3
DK1214097T3 DK00965119T DK00965119T DK1214097T3 DK 1214097 T3 DK1214097 T3 DK 1214097T3 DK 00965119 T DK00965119 T DK 00965119T DK 00965119 T DK00965119 T DK 00965119T DK 1214097 T3 DK1214097 T3 DK 1214097T3
Authority
DK
Denmark
Prior art keywords
nucleic acids
acids encoding
polyepitope polypeptides
encoding polyepitope
polypeptides
Prior art date
Application number
DK00965119T
Other languages
Danish (da)
English (en)
Inventor
Roman M Chicz
Robert C Urban
Mary Lynne Hedley
Original Assignee
Eisai Corp North America
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Corp North America filed Critical Eisai Corp North America
Application granted granted Critical
Publication of DK1214097T3 publication Critical patent/DK1214097T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK00965119T 1999-09-16 2000-09-18 Nukleinsyrer kodende for polyepitop-polypeptider DK1214097T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US15466599P 1999-09-16 1999-09-16
US39853499A 1999-09-16 1999-09-16
US16984699P 1999-12-09 1999-12-09
US45817399A 1999-12-09 1999-12-09
PCT/US2000/025559 WO2001019408A1 (fr) 1999-09-16 2000-09-18 Acides nucleiques codant pour des polypeptides de polyepitopes

Publications (1)

Publication Number Publication Date
DK1214097T3 true DK1214097T3 (da) 2009-11-16

Family

ID=27496146

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00965119T DK1214097T3 (da) 1999-09-16 2000-09-18 Nukleinsyrer kodende for polyepitop-polypeptider

Country Status (10)

Country Link
EP (2) EP2100620A1 (fr)
JP (1) JP2003509035A (fr)
AU (1) AU785319B2 (fr)
CA (1) CA2384987A1 (fr)
CY (1) CY1109699T1 (fr)
DE (1) DE60042556D1 (fr)
DK (1) DK1214097T3 (fr)
ES (1) ES2330078T3 (fr)
PT (1) PT1214097E (fr)
WO (1) WO2001019408A1 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2399058A1 (fr) * 2000-02-02 2001-08-09 Transgene S.A. Peptides capables de ciblage
FR2824326B1 (fr) * 2001-05-04 2004-03-19 Commissariat Energie Atomique Melange de peptides issus des proteines e6 et/ou e7 de papillomavirus et leurs applications
GB0118532D0 (en) 2001-07-30 2001-09-19 Isis Innovation Materials and methods relating to improved vaccination strategies
DE60238864D1 (de) 2001-11-07 2011-02-17 Mankind Corp Für epitope von antigenen kodierende expressionsvektoren und verfahren zu deren konzeption
AU2003229429A1 (en) * 2002-05-07 2003-11-11 Aventis Pasteur, Ltd. Polyepitopes and mini-genes for cancer treatment
AU2002950183A0 (en) * 2002-07-12 2002-09-12 The Council Of The Queensland Institute Of Medical Research Expression of hydrophobic proteins
JP2006503914A (ja) * 2002-10-21 2006-02-02 エムジーアイ ファーマ バイオロジックス インコーポレイテッド ヒトパピローマウイルス媒介性疾患を治療するための組成物および方法
ATE520708T1 (de) 2003-03-28 2011-09-15 Us Gov Health & Human Serv Immunogenetische hiv-1 multi-klade, multivalente konstrukte und deren verwendung
CA2528727A1 (fr) * 2003-06-10 2004-12-16 The University Of Melbourne Compositions immuno-modulatrices, leurs utilisations et leurs procedes de production
US8877206B2 (en) 2007-03-22 2014-11-04 Pds Biotechnology Corporation Stimulation of an immune response by cationic lipids
US9789129B2 (en) 2008-04-17 2017-10-17 Pds Biotechnology Corporation Stimulation of an immune response by enantiomers of cationic lipids
WO2011110953A2 (fr) * 2010-03-09 2011-09-15 Artemev, Timur Constructions polyépitopiques et leurs procédés de préparation et d'utilisation
CN103180343B (zh) 2010-08-13 2016-01-20 株式会社吉耐森 用于预防或治疗宫颈癌的、包含人乳头瘤病毒变形体及免疫增强剂的组合物
CN105463000B (zh) * 2010-08-13 2021-06-01 株式会社吉耐森 用于预防或治疗宫颈癌的、包含人乳头瘤病毒变形体及免疫增强剂的组合物
CN105463001A (zh) * 2010-08-13 2016-04-06 株式会社吉耐森 用于预防或治疗宫颈癌的、包含人乳头瘤病毒变形体及免疫增强剂的组合物
RS59369B1 (sr) 2011-05-24 2019-11-29 Biontech Rna Pharmaceuticals Gmbh Individualizovane vakcine protiv kancera
BR112013029834A8 (pt) 2011-05-24 2022-10-18 Biontech Ag vacinas individualizadas para câncer
TWI672149B (zh) 2012-09-21 2019-09-21 美商Ｐｄｓ生技公司 改良之疫苗組成物及使用方法
MX2017002081A (es) 2014-08-15 2017-05-23 Genexine Inc Metodo para tratar cancer de cuello uterino.
SG11201702997YA (en) * 2014-11-04 2017-05-30 Janssen Vaccines & Prevention Bv Therapeutic hpv16 vaccines
AU2016354590B2 (en) 2015-11-13 2023-11-23 Pds Biotechnology Corporation Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy
EP3386593A4 (fr) * 2015-12-09 2019-07-24 Admedus Vaccines Pty Ltd Composition immunomodulatrice pour le traitement
CN110035765B (zh) 2016-10-05 2024-04-02 Pds生物科技公司 新型hpv16非hla限制性t细胞疫苗、组合物及其使用方法
US11111277B2 (en) * 2016-12-28 2021-09-07 Invvax, Inc. Influenza vaccines
JP7457642B2 (ja) * 2017-04-03 2024-03-28 ビオンテック ユーエス インコーポレイテッド タンパク質抗原およびその使用
US20210393757A1 (en) * 2018-10-01 2021-12-23 The Wistar Institute Melanoma Canine Vaccine Compositions and Methods of Use Thereof
BR112022021284A2 (pt) 2020-04-24 2022-12-06 Genexine Inc Composição farmacêutica, seu uso para tratar ou prevenir um câncer induzido pelo vírus do papiloma humano, e combinação

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990003984A1 (fr) * 1988-10-03 1990-04-19 Repligen Corporation Proteines et peptides du vih utiles pour le diagnostic, la prophylaxie ou la therapie du sida
IE910909A1 (en) * 1990-03-20 1991-09-25 Behringwerke Ag Seroreactive epitopes of human Papillomavirus (HPV) 16¹proteins
US5753233A (en) * 1990-05-10 1998-05-19 Behring Diagnostics Gmbh Seroreactive epitopes on proteins of human papilloma-virus (HPV) 18
DE4015044A1 (de) * 1990-05-10 1991-11-14 Behringwerke Ag Seroreaktive epitope auf proteinen des menschlichen papillomavirus (hpv) 18
SE9001705D0 (sv) * 1990-05-11 1990-05-11 Medscand Ab Saett foer diagnostik av virusbaerande tumoerer genom immunoassay
WO1992005248A1 (fr) * 1990-09-26 1992-04-02 Bristol-Myers Squibb Company Expression de proteines virales du papillome humain et utilisation dans des compositions immunogeniques
GB9105383D0 (en) * 1991-03-14 1991-05-01 Immunology Ltd An immunotherapeutic for cervical cancer
ATE234860T1 (de) * 1991-07-13 2003-04-15 Dade Behring Marburg Gmbh Verwendung von hpv-16 e6 und e7-gen gewonnen peptiden für den diagnostischen zweck
IL105554A (en) * 1992-05-05 1999-08-17 Univ Leiden Peptides of human papillomavirus for use in preparations elicit a human T cell response
EP0671926B1 (fr) 1992-08-11 2002-11-13 President And Fellows Of Harvard College Peptides immunomodulateurs
US5679509A (en) * 1993-09-28 1997-10-21 University Of New Mexico Methods and a diagnostic aid for distinguishing a subset of HPV that is associated with an increased risk of developing cervical dysplasia and cervical cancer
WO1995024929A2 (fr) 1994-03-15 1995-09-21 Brown University Research Foundation Systeme de liberation de genes polymeres
AUPN015794A0 (en) * 1994-12-20 1995-01-19 Csl Limited Variants of human papilloma virus antigens
US5783567A (en) 1997-01-22 1998-07-21 Pangaea Pharmaceuticals, Inc. Microparticles for delivery of nucleic acid
US6013258A (en) * 1997-10-09 2000-01-11 Zycos Inc. Immunogenic peptides from the HPV E7 protein

Also Published As

Publication number Publication date
WO2001019408A1 (fr) 2001-03-22
EP1214097B3 (fr) 2011-07-20
ES2330078T3 (es) 2009-12-04
CA2384987A1 (fr) 2001-03-22
DE60042556D1 (de) 2011-02-10
WO2001019408A9 (fr) 2002-12-05
JP2003509035A (ja) 2003-03-11
CY1109699T1 (el) 2014-08-13
EP2100620A1 (fr) 2009-09-16
EP1214097B1 (fr) 2009-07-15
EP1214097A1 (fr) 2002-06-19
PT1214097E (pt) 2009-10-19
EP1214097A4 (fr) 2005-02-02
EP1214097B9 (fr) 2010-05-19
AU7589100A (en) 2001-04-17
AU785319B2 (en) 2007-01-11

Similar Documents

Publication Publication Date Title
DK1214097T3 (da) Nukleinsyrer kodende for polyepitop-polypeptider
DE60022665D1 (de) Immunstimulierende nukeinsäuren
EE200300107A (et) Uued retseptori nukleiinhapped ja polüpeptiidid
AU2001234944A8 (en) Novel nucleic acids and polypeptides
EP1504099A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1381621A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1432800A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1470238A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1325120A4 (fr) Acides nucleiques et polypeptides
EP1341804A4 (fr) Nouveaux acides nucleiques et polypeptides
DE60015796D1 (de) Neue aminopropylphosphinsäuren
EP1430112A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1276751A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1368475A4 (fr) Nouveaux acides nucleiques et nouveaux polypeptides
ATE207112T1 (de) Tresteruntertaucheinrichtung zur weinherstellung
AU8308901A (en) Novel proteins and nucleic acids encoding same
EP1341803A4 (fr) Nouveaux acides nucleiques et polypeptides
FR2791348B1 (fr) POLYPEPTIDE Npt2B
AU2002339862A8 (en) Abrogen polypeptides, nucleic acids encoding them and methods for using them to inhibit angiogenesis
NO20021614D0 (no) DNA kodende for PROST 07-polypeptid
IL145785A0 (en) Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same
PT1171454E (pt) Acidos nucleicosos e polipeptidos quimericos do lyssavirus
EP1282635A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1268762A4 (fr) Nouveaux acides nucleiques et polypeptides
NO20022542D0 (no) DNA som koder for et nytt PROST-Ets-polypeptid